Key result
L-NMMA potentiates thrombin-stimulated ET-1 release in intact aorta, indicating NO downregulates ET-1 production.
The study demonstrates that nitric oxide downregulates thrombin-stimulated endothelin-1 production in intact porcine aorta, a regulatory mechanism that appears lost in cultured endothelial cells.
Answers are grounded in this paper and cite their sources.
NO-ET-1 regulation differs in intact vs cultured vessels; leaves open translation to human endothelial dysfunction or therapy.
The effect of the inhibition of the release of endothelium-derived nitric oxide (NO) by L-NG-monomethylarginine (L-NMMA) on the production of endothelin-1 (ET-1) was studied both in intact porcine aorta and in cultured porcine aortic endothelial cells. The basal production of endothelin was not affected by L-NMMA or by SIN-1, but was significantly increased in the presence of thrombin under both experimental conditions. In the intact porcine aorta, the thrombin-stimulated release of the peptide was potentiated in the presence of L-NMMA, demonstrating that the thrombin-stimulated release of NO downregulates the concomitant production of endothelin. In contrast, in cultured endothelial cells obtained from the porcine aorta, L-NMMA did not affect the thrombin-stimulated release of the peptide, suggesting that the regulatory mechanism in cultured endothelial cells is not linked to the production of ET-1.
No takes yet. Share an insight, caveat, or question.
Boulanger et al. (1991) studied this question. L-NMMA was evaluated on Production of endothelin-1 (ET-1). L-NMMA potentiated thrombin-stimulated release of endothelin-1 in intact porcine aorta, but not in cultured porcine aortic endothelial cells, indicating NO downregulates ET-1 production in intact tissue.
Synapse has enriched 10 related papers. Consider them for comparative context: